Bipsee raises Series A extension for VR digital therapy, securing new funding to support clinical trials. The investment comes from JIC Venture Growth Investments and Kyoto University Innovation Capital.
Round Type
Series A
TokyoHealth CareVirtual RealityInvestors
Description
Tokyo-based Bipsee has completed the second close of its Series A through a third-party allotment of new shares. The new capital will support an ongoing confirmatory clinical trial for their VR digital therapy for psychiatric conditions. Bipsee's raise signals institutional interest in digital therapeutics in Japan. The therapy is pending regulatory approval after priority review by the Ministry of Health, Labour and Welfare.
Quick answer
BiPSEE raised an undisclosed amount in a Series A round, dated August 17, 2026. Investors: Kyoto University Innovation Capital and JIC Venture Growth Investments. BiPSEE is based in Tokyo, Tokyo, Japan.
- How much did BiPSEE raise?
- BiPSEE raised an undisclosed amount in a Series A round on August 17, 2026.
- Who invested in BiPSEE?
- Kyoto University Innovation Capital and JIC Venture Growth Investments are named as investors in this round.
- What does BiPSEE do?
- BiPSEE is a developer of VR digital therapy (VRx) for depression, utilizing VR headsets and smartphone apps to improve the psychological state of patients affected by ruminative thoughts.
- Where is BiPSEE based and how big is it?
- BiPSEE is based in Tokyo, Tokyo, Japan. Fundz records about 4 employees.
- Who are the decision-makers at BiPSEE?
- Fundz holds 1 contact at BiPSEE. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Virtual Reality and Health Care around the same time
Companies in the same sectors as BiPSEE that raised within 45 days of this round, from Fundz verified event records.
- Parakeet Health raised $10M (Series A) on October 1, 2026.
- SedMed raised $4M (Seed) on October 1, 2026.
- TriGemX Bio raised $94M on October 1, 2026.
- Devoted Health raised $1.2B on October 1, 2026.
- Biotia raised $9M on October 1, 2026.
- Mangoceuticals raised $1.3M (Post-IPO Equity) on October 1, 2026.
Who to call at BiPSEE, and when
A new round usually means BiPSEE is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BiPSEE raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BiPSEE, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BiPSEE. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BiPSEE raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBiPSEE raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.